¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"activator constant"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • activator
    1. Ȱ¼ºÁ¦ 2. Åα³Á¤ÀåÄ¡
  • activator reaction
    Ȱ¼ºÁ¦¹ÝÀÀ
  • catabolite (gene) activator protein
    ºÐÇØ´ë»ç»ê¹°(À¯ÀüÀÚ)Ȱ¼º´Ü¹éÁú
  • catabolite activator protein
    ºÐÇØ´ë»ç»ê¹°È°¼º´Ü¹éÁú
  • polyclonal activator
    ´ÙŬ·ÐȰ¼ºÁ¦
  • antigen diffusion constant
    Ç׿øÈ®»ê»ó¼ö
  • association constant
    ¿¬ÇÕ»ó¼ö, °áÇÕ»ó¼ö
  • affinity constant
    ģȭ»ó¼ö
  • absolute constant
    Àý´ë»ó¼ö
  • computer-guided constant infusion
    ÄÄÇ»ÅÍÀ¯µµÇ×¼ÓÁÖÀÔ
  • constant
    »ó¼ö
  • constant bias
    »óÁ¸Ä¡¿ìħ
  • constant carrier
    °è¼Óº¸±ÕÀÚ
  • constant friction knee
    Á¤¸¶Âû¹«¸­°üÀý
  • constant gradient
    °íÁ¤±â¿ï±â
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • constant
    »ó¼ö
  • activator
    1. Ȱ¼ºÁ¦, 2. Åα³Á¤ÀåÄ¡
  • tissue plasminogen activator
    Á¶Á÷Çö󽺹̳ë°ÕȰ¼ºÁ¦
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • activator
    Ȱ¼ºÁ¦, Åα³Á¤ÀåÄ¡
  • activator reaction
    Ȱ¼ºÁ¦¹ÝÀÀ
  • polyclonal activator
    ´ÙŬ·ÐȰ¼ºÁ¦
  • absolute constant
    Àý´ë»ó¼ö
  • affinity constant
    ģȭ»ó¼ö
  • air kerma-rate constant
    °ø±âÄ¿¸¶À²»ó¼ö
  • antigen diffusion constant
    Ç׿øÈ®»ê»ó¼ö
  • association constant
    ¿¬ÇÕ»ó¼ö, °áÇÕ»ó¼ö
  • constant bias
    »óÁ¸ÆíÀç
  • constant
    »ó¼ö
  • computer-guided constant infusion
    ÄÄÇ»ÅÍÀ¯µµÇ×¼ÓÁÖÀÔ
  • constant carrier
    °è¼Óº¸±ÕÀÚ
  • constant gradient
    °íÁ¤±â¿ï±â
  • constant pain
    Áö¼ÓÅë
  • constant region
    ºÒº¯ºÎÀ§
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • activator
    Ȱ¼ºÈ­Á¦(üÀàõûúð¥), ºÎȰü(Ý·üÀô÷). Ä¡°ú,»ýÈ­±â´ÉÀû ¾Ç±³Á¤ÀåÄ¡(ѦÒöîÜäÉÎìïáíûöÇ).
  • activator
    Ȱ¼ºÁ¦(üÀàõð¥), ºÎȰü(Ý·üÀô÷). [Ä¡°ú,»ýÈ­]±â´ÉÀû ¾Ç±³Á¤ÀåÄ¡(ѦÒöîÜäÉÎìïáíûöÇ).
  • activator reaction
    Ȱ¼ºÈ­¹ÝÀÀ.
  • acyl-plasminogen streptokinase activator complex
    ¾Æ½Ç-Çø®Áî¹Ì³ë°Õ½ºÆ®·¾ÅäŰ³ªÁ¦È°¼ºÁ¦º¹ÇÕü
  • ganglioside activator protein
    °»±Û¸®¿À»çÀ̵å Ȱ¼º´Ü¹éÁú
  • plasmin activator
    Çö󽺹ÎȰ¼ºÁ¦(¡­üÀàõð¥)
  • plasminogen activator
    ÇöóÁî¹Ì³ë°ÕȰ¼º <¹°Áú>.
  • plasminogen activator
    Çö󽺹̳ë°Õ Ȱ¼ºÀÎÀÚ
  • polyclonal activator
    ´Ù(¼ö)Ŭ·ÐȰ¼ºÁ¦, ¿©·¯¹«¸®È°¼ºÁ¦
  • Boltzman constant Boltzman
    »ó¼ö
  • Goldman constant-field equation
    °ñµå¸¸ Á¤Àü·ù(ïÒï³×µ) ½Ä
  • Length constant
    ±æÀÌÁö¼ö(¡­ò¦â¦)
  • Plancks constant
    ÇöûÅ©»ó¼ö(ßÈâ¦)
  • Planks constant
    ÇöûÅ©»ó¼ö
  • absolute constant
    Àý´ë»ó¼ö(¡­ßÈâ¦)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • activator
    Ȱ¼ºÁ¦(üÀàõð¥), ºÎȰü(Ý·üÀô÷). [Ä¡°ú,»ýÈ­]±â´ÉÀû ¾Ç±³Á¤ÀåÄ¡(ѦÒöîÜäÉÎìïáíûöÇ).
  • activator
    Ȱ¼ºÈ­Á¦(üÀàõûúð¥), ºÎȰü(Ý·üÀô÷). Ä¡°ú,»ýÈ­±â´ÉÀû ¾Ç±³Á¤ÀåÄ¡(ѦÒöîÜäÉÎìïáíûöÇ).
  • activator reaction
    Ȱ¼ºÈ­¹ÝÀÀ.
  • acyl-plasminogen streptokinase activator complex
    ¾Æ½Ç-Çø®Áî¹Ì³ë°Õ½ºÆ®·¾ÅäŰ³ªÁ¦È°¼ºÁ¦º¹ÇÕü
  • enzyme activator
    È¿¼ÒȰ¼ºÁ¦.
  • ganglioside activator protein
    °»±Û¸®¿À»çÀ̵å Ȱ¼º´Ü¹éÁú
  • plasmin activator
    Çö󽺹ÎȰ¼ºÁ¦(¡­üÀàõð¥)
  • plasminogen activator
    Çö󽺹̳ë°Õ Ȱ¼ºÀÎÀÚ
  • plasminogen activator
    ÇöóÁî¹Ì³ë°ÕȰ¼º <¹°Áú>.
  • polyclonal activator
    ´Ù(¼ö)Ŭ·ÐȰ¼ºÁ¦, ¿©·¯¹«¸®È°¼ºÁ¦
  • sphingolipid activator protein I deficiency
  • tissue plasminogen activator
  • absolute constant
    Àý´ë»ó¼ö(¡­ßÈâ¦)
  • affinity constant
    ģȭ»ó¼ö(öÑûúßÈâ¦)
  • air kerma-rate constant
    °ø±âÄ¿¸¶À²»ó¼ö
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • activator constant
    Ȱ¼ºÈ­Á¦ Ç×¼ö(üÀàõûùð¥ùöâ¦)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • activator
    Ȱ¼ºÈ­Á¦(üÀàõûùð¥)
  • catabolite activator protein
    īŸº¼¶óÀÌÆ® Ȱ¼ºÈ­ ´Ü¹éÁú(üÀàõûùÓ±ÛÜòõ)
  • plasminogen activator
    Çö󽺹̳ëÀü Ȱ¼ºÀÚ(üÀàõí­)
  • tissue plasminogen activator
    Á¶Á÷(ðÚòÄ)Çö󽺹̳ëÀü Ȱ¼ºÀÚ (üÀàõí­)
  • affinity constant
    ģȭ»ó¼ö(öÑûúßÈâ¦)
  • allosteric constant
    ¾Ë·Î½ºÅ׸® »ó¼ö(ßÈâ¦)
  • association constant
    ¿¬ÇÕ»ó¼ö(æáùêßÈâ¦)
  • average intrinsic association constant
    Æò±Õ°íÀ¯¿¬ÇÕ»ó¼ö (øÁгͳêóæáùêßÈâ¦)
  • basicity constant
    ¿°±â(µµ)»ó¼ö(ç¤Ðñ(Óø)ßÈâ¦)
  • binding constant
    °áÇÕ»ó¼ö(Ì¿ùêßÈâ¦)
  • catalytic constant
    Ã˸Żó¼ö(õºØÚßÈâ¦)
  • catalytic rate constant
    Ã˸żӵµ»ó¼ö(õºØÚáÜÓøßÈâ¦)
  • concentration equilibrium constant
    "³óµµÆòÇü»ó¼ö(ÒØÓøøÁû¬ßÈâ¦), (ÔÒ) apparent equilibrium constant"
  • constant region
    ºÒº¯±¸¿ª(ÝÕܨϡæ´)
  • coupling constant
    ¦Áþ±â »ó¼ö(ßÈâ¦)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Boltzman constant
    Boltzman»ó¼ö
  • constant
    »ó¼ö, ÀÏÁ¤ÀÇ, ºÒº¯ÀÇ, »óÁ¸¼ºÀÇ
  • constant field gradient spin echo method
    °íÁ¤°æ»çÀ彺ÇÉ¿¡ÄÚ¹ý
  • constant gradient
    °íÁ¤°æ»ç
  • constant velocity
    °íÁ¤¼Óµµ
  • decay constant
    ºØ±«»ó¼ö
  • fast time constant circuit
    °í¼Ó½Ã°£°íÁ¤È¸·Î
  • quantum constant
    ¾çÀÚ»ó¼ö
  • radioactive constant
    ¹æ»ç´É»ó¼ö
  • spin spin coupling constant (J)
    ½ºÇɽºÇÉÄ¿Çøµ»ó¼ö (J)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
APSAC acylated plasminogen-streptokinase activator complex; anisoylated plasminogen streptokinase activato...
APSAC   1) Acylating the Plasminogen Streptokinase Activated Complex
  2) Anisoylat...
rt-PA recombinant tissue-Plasminogen Activator
  = Alteplase
tPA tissue Plasminogen Activator
CAP camptodactyly-arthropathy-pericarditis [syndrome]; Canada Assistance Plan; capsule; captopril; catab...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
C Constant
CDCE Constant Denaturant Capillary Electrophoresis
CE Constant Estrus
CS Constant Spring
CDGE Constant denaturant gel electrophoresis
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • acyl-plasminogen streptokinase activator complex
    ¾Æ½Ç-Çø®Áî¹Ì³ë°Õ½ºÆ®·¾ÅäŰ³ªÁ¦ Ȱ¼º
  • enzyme activator
    È¿¼Ò Ȱ¼ºÁ¦
  • recombinant plasminogen activator
    ÀçÁ¶ÇÕ Çö󽺹̳ë°Õ Ȱ¼ºÁ¦
  • absolute constant
    Àý´ë »ó¼ö
  • accommodation constant
    ÀûÀÀ »ó¼ö
  • affinity constant
    ģȭ »ó¼ö
  • Boltzman constant
    Boltzman »ó¼ö
  • constant
    »ó¼ö, ÀÏÁ¤ÀÇ, ºÒº¯ÀÇ, »óÁ¸ÀÇ, »óÁ¸¼ºÀÇ
    ÁÙ°ð, °è¼Ó, ¹«º¯È­ ±×´ë·Î.
  • constant current
    Á¤Àü·ù
  • constant field equation
    Á¤ÀüÀå ¹æÁ¤½Ä
  • constant force
    Ç×·Â
  • constant pain
    Áö¼ÓÅë
  • constant temperature
    Ç׿Â
  • constant turn over
    ÀÏÁ¤ÇÑ È¸Àü
  • constant volume
    ÀÏÁ¤ ºÎÇÇ, Á¤Àû
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
activator <biochemistry> A DNA-binding transcription metabolite that positively modulates an allosteric enzyme or regulates one or more genes by increasing the rate of transcription.
(12 Mar 1998)
activator appliances Loose-fitting removable orthodontic appliances which redirect the pressures of the facial and masticatory muscles onto the teeth and their supporting structures to produce improvements in tooth arrangements and occlusal relations.
(12 Dec 1998)
catabolite gene activator catabolite (gene) activator protein
catabolite gene activator protein <molecular biology, protein> A regulatory protein that triggers the transcription of genes that generate the enzymes bacteria need to usenutrients when glucose isabsent.
(16 Mar 1998)
catabolite (gene) activator protein A protein that can be activated by cAMP, whereupon it affects the action of RNA polymerase by binding it with it or near it on the DNA to be transcribed.
Synonym: cAMP receptor protein, catabolite gene activator.
(05 Mar 2000)
plasminogen activator <enzyme> Serine protease that acts on plasminogen to generate plasmin. Has also been implicated in invasiveness and is produced by many normal and invasive cells. The vascular form (tPA, 55 kD) is very similar to tissue plasminogen activator (uPA, 70 kD) and to streptokinase and urokinase.
(18 Nov 1997)
plasminogen activator inhibitor 1 <chemical> A member of the serpin family of proteins. It inhibits both the tissue-type and urokinase-type plasminogen activator.
Pharmacological action: serine proteinase inhibitors.
(12 Dec 1998)
plasminogen activator inhibitor 2 <chemical> Member of the serpin family of proteins. It inhibits both the tissue-type and urokinase-type plasminogen activator.
Pharmacological action: serine proteinase inhibitors.
(12 Dec 1998)
polyclonal activator A substance that will activate T-cells, B-cells, or both regardless of their specificities.
(05 Mar 2000)
protein activator, aminolevulinic acid synthetase <chemical> From rat liver mitochondria
Synonym: aminolevulinic acid synthetase activator
(26 Jun 1999)
tissue plasminogen activator <enzyme> Plasma serine protease, one of a closely related group of plasminogen activators. Contains an EGF like domain and multiple copies of the kringle domain.
(18 Nov 1997)
kidney plasminogen activator <protein> A precursor to the enzyme urokinase that has blood clotting properties.
(14 Nov 1997)
acid dissociation constant <chemistry> This is the equilibrium constant for the breaking apart of a weak acid into its hydrogen and conjugate base in a water solution.
(09 Oct 1997)
Ambard's constant <physiology> Obsolete law's for output of urea:
1. With the urinary urea concentration constant, urea output varies directly as the square of the concentration of the blood urea.
2. With the blood urea concentration constant, urea output varies inversely as the square root of its urinary concentration.
(05 Mar 2000)
association constant <chemistry> Reciprocal of dissociation constant. A measure of the extent of a reversible association between two molecular species at equilibrium.
(18 Nov 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • activator
    Ȱµ¿ÀûÀÌ µÇ°Ô ÇÏ´Â »ç¶÷;Ȱ¼º¹°;Ȱ¼ºÁ¦;Ȱ¼ºÃ¼
  • constant
    ºÒÆíÀÇ,ºÎ´ÜÇÑ
  • Cuie constant
    =CURIAGE
  • Hubble's constant
    ÇãºíÁ¤¼ö(ÀºÇÏ ÈÄÅð ¼Óµµ°¡ °Å¸®¿¡ ºñ·ÊÇÏ¿© Áõ°¡ÇÏ´Â ºñÀ²)
  • constant
    ºÒº¯ÀÇ;ÀÏÁ¤ÇÑ;²÷ÀÓ ¾øÀÌ °è¼ÓÇÏ´Â;ºÎ´ÜÇÑ;Ãæ½ÇÇÑ;Àý°³°¡ ±»Àº;°ß½ÇÇÑ;³¡±îÁö ÁöŰ´Â;»ó¼ö;ºÒº¯¼ö(·®);À²
  • constant-level balloon
    Á¤ °íµµ±â±¸
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á